Harvard Bioscience, Inc. (NASDAQ:HBIO)

Sunday, May 2, 2010 | Web News
Commenting on the Company's performance, Chane Graziano, CEO, stated, "First quarter 2010 was an outstanding quarter for Harvard Bioscience. Revenues were up 38%...
See All Research...
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

Web site: http://www.harvardbioscience.com

Last updated July 30, 2008


Market Data powered by QuoteMedia. Terms of Use